HHS is standing up two new FDA deputy commissioner posts, with a medtech veteran tipped to oversee AI.
A Nature Medicine Comment outlines a Nordic AI-Health Initiative platform built on pooled regional health data.
FDA and CMS hosted 10 AI health companies at a private demo day as they weigh clinical AI policy.
The Federation of State Medical Boards argues generative AI belongs inside existing physician oversight, not in a separate license.
Medicare outlines plans to build standardized reimbursement for AI tools tied to patient outcomes
Medicare proposes a standardized payment structure for AI clinical tools based on patient outcomes.
Blumenthal and Hawley demand records from UnitedHealth, Humana and CVS on AI use to block rehabilitative care.